Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Dec-2025 | 715.05 | 724 | 705.1 | 716.1 | 46,408 | 94,82,28,691.15 | 5,34,268 |
02-Dec-2025 | 713 | 714.9 | 695.1 | 698.7 | 31,007 | 46,21,17,578.1 | 2,98,223 |
03-Dec-2025 | 698.6 | 698.8 | 681.1 | 688.1 | 25,784 | 42,32,48,521.5 | 2,85,918 |
04-Dec-2025 | 687 | 698.4 | 680.1 | 683.7 | 35,930 | 50,79,19,130.9 | 3,62,915 |
05-Dec-2025 | 685 | 697.2 | 672.75 | 686.9 | 21,267 | 41,66,51,365.3 | 2,59,754 |
08-Dec-2025 | 683.4 | 687.6 | 657.9 | 673.55 | 39,491 | 61,68,69,885.9 | 4,75,772 |
09-Dec-2025 | 665 | 708.5 | 665 | 702.95 | 23,083 | 30,54,00,368.95 | 2,04,942 |
10-Dec-2025 | 709.35 | 709.4 | 680 | 681.95 | 26,354 | 29,48,01,880.95 | 2,02,073 |
11-Dec-2025 | 685.6 | 699.3 | 667 | 694.95 | 29,020 | 45,42,80,589.7 | 2,72,910 |
12-Dec-2025 | 698.7 | 707.6 | 688.6 | 700.5 | 18,248 | 33,19,85,509.2 | 1,95,838 |
15-Dec-2025 | 700.5 | 700.55 | 688.35 | 696.55 | 14,693 | 18,01,89,948.75 | 1,17,506 |
16-Dec-2025 | 697 | 702.45 | 692 | 695.35 | 8,660 | 10,57,26,567.4 | 68,476 |
17-Dec-2025 | 693.25 | 695.55 | 669 | 671.15 | 20,726 | 21,41,79,474.55 | 1,60,581 |
18-Dec-2025 | 670.1 | 677 | 655.2 | 672.9 | 29,111 | 61,47,30,028.35 | 4,04,435 |
19-Dec-2025 | 676.9 | 682 | 667.55 | 675.7 | 14,657 | 13,00,21,636.3 | 99,668 |
22-Dec-2025 | 680 | 700 | 675.7 | 695.7 | 14,719 | 24,92,22,307.2 | 2,09,060 |
23-Dec-2025 | 694.9 | 701 | 684.1 | 696.35 | 20,438 | 30,12,03,828.45 | 2,26,706 |
24-Dec-2025 | 692.1 | 696.1 | 686.35 | 689.35 | 10,372 | 13,55,00,966.8 | 1,10,776 |
26-Dec-2025 | 685.7 | 692.75 | 680.15 | 685.8 | 15,342 | 15,70,15,248.3 | 1,34,644 |
29-Dec-2025 | 686.3 | 695.1 | 681 | 682.4 | 13,495 | 25,24,33,679.65 | 2,52,143 |
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
